Occurrence of major anti-retinal autoantibodies associated with paraneoplastic autoimmune retinopathy

Grazyna Adamus; Rachel Champaigne; Sufang Yang

doi:10.1016/j.clim.2019.108317

Occurrence of major anti-retinal autoantibodies associated with paraneoplastic autoimmune retinopathy

Grazyna Adamus, Rachel Champaigne, Sufang Yang

Ophthalmology

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Abstract

Autoantibodies (AAbs) against retinal antigens can be found in patients with cancer and unexplained vision loss unrelated to the cancer metastasis. Cancer-associated retinopathy (CAR) is a rare paraneoplastic visual syndrome mediated by AAbs. Our goal was to determine whether CAR patients with different malignancies have a specific AAb or repertoire of AAbs that could serve as biomarkers for retinal disease. We found AAbs against 12 confirmed retinal antigens, with α-enolase being the most frequently recognized. The significant finding of the study was a high incidence of anti-aldolase AAbs in colon-CAR, anti-CAII in prostate-CAR, and anti-arrestin in skin melanoma patients thus these AAbs could serve as biomarkers in the context of clinical presentation and could support the diagnosis of CAR. However, a lack of AAb restriction to any one antigenic protein or to one retinal cellular location makes screening for a CAR biomarker challenging.

Original language	English (US)
Article number	108317
Journal	Clinical Immunology
Volume	210
DOIs	https://doi.org/10.1016/j.clim.2019.108317
State	Published - Jan 2020

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1016/j.clim.2019.108317

Cite this

@article{ef4b9d32ecef43999205bdb2d998a357,

title = "Occurrence of major anti-retinal autoantibodies associated with paraneoplastic autoimmune retinopathy",

abstract = "Autoantibodies (AAbs) against retinal antigens can be found in patients with cancer and unexplained vision loss unrelated to the cancer metastasis. Cancer-associated retinopathy (CAR) is a rare paraneoplastic visual syndrome mediated by AAbs. Our goal was to determine whether CAR patients with different malignancies have a specific AAb or repertoire of AAbs that could serve as biomarkers for retinal disease. We found AAbs against 12 confirmed retinal antigens, with α-enolase being the most frequently recognized. The significant finding of the study was a high incidence of anti-aldolase AAbs in colon-CAR, anti-CAII in prostate-CAR, and anti-arrestin in skin melanoma patients thus these AAbs could serve as biomarkers in the context of clinical presentation and could support the diagnosis of CAR. However, a lack of AAb restriction to any one antigenic protein or to one retinal cellular location makes screening for a CAR biomarker challenging.",

author = "Grazyna Adamus and Rachel Champaigne and Sufang Yang",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",

year = "2020",

month = jan,

doi = "10.1016/j.clim.2019.108317",

language = "English (US)",

volume = "210",

journal = "Clinical Immunology",

issn = "1521-6616",

publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Occurrence of major anti-retinal autoantibodies associated with paraneoplastic autoimmune retinopathy

AU - Adamus, Grazyna

AU - Champaigne, Rachel

AU - Yang, Sufang

PY - 2020/1

Y1 - 2020/1

N2 - Autoantibodies (AAbs) against retinal antigens can be found in patients with cancer and unexplained vision loss unrelated to the cancer metastasis. Cancer-associated retinopathy (CAR) is a rare paraneoplastic visual syndrome mediated by AAbs. Our goal was to determine whether CAR patients with different malignancies have a specific AAb or repertoire of AAbs that could serve as biomarkers for retinal disease. We found AAbs against 12 confirmed retinal antigens, with α-enolase being the most frequently recognized. The significant finding of the study was a high incidence of anti-aldolase AAbs in colon-CAR, anti-CAII in prostate-CAR, and anti-arrestin in skin melanoma patients thus these AAbs could serve as biomarkers in the context of clinical presentation and could support the diagnosis of CAR. However, a lack of AAb restriction to any one antigenic protein or to one retinal cellular location makes screening for a CAR biomarker challenging.

AB - Autoantibodies (AAbs) against retinal antigens can be found in patients with cancer and unexplained vision loss unrelated to the cancer metastasis. Cancer-associated retinopathy (CAR) is a rare paraneoplastic visual syndrome mediated by AAbs. Our goal was to determine whether CAR patients with different malignancies have a specific AAb or repertoire of AAbs that could serve as biomarkers for retinal disease. We found AAbs against 12 confirmed retinal antigens, with α-enolase being the most frequently recognized. The significant finding of the study was a high incidence of anti-aldolase AAbs in colon-CAR, anti-CAII in prostate-CAR, and anti-arrestin in skin melanoma patients thus these AAbs could serve as biomarkers in the context of clinical presentation and could support the diagnosis of CAR. However, a lack of AAb restriction to any one antigenic protein or to one retinal cellular location makes screening for a CAR biomarker challenging.

UR - http://www.scopus.com/inward/record.url?scp=85075870901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075870901&partnerID=8YFLogxK

U2 - 10.1016/j.clim.2019.108317

DO - 10.1016/j.clim.2019.108317

M3 - Article

C2 - 31770612

AN - SCOPUS:85075870901

SN - 1521-6616

VL - 210

JO - Clinical Immunology

JF - Clinical Immunology

M1 - 108317

ER -

Occurrence of major anti-retinal autoantibodies associated with paraneoplastic autoimmune retinopathy

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this